Further evidence for an antidepressant potential of the selective σ1 agonist SA 4503: Electrophysiological, morphological and behavioural studies

International Journal of Neuropsychopharmacology

Volumn 11, Issue 4, 2008, Pages 485-495

  Lucas, Guillaume ^a,b   Rymar, Vladimir V ^c   Sadikot, Abbas F ^c   Debonnel, Guy ^a  

^a MCGILL UNIVERSITY   (Canada)

^b CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

5 HT neuron activity; Brain cell proliferation; In vivo electrophysiology; SA 4503; 1 receptor agonist

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; BROXURIDINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CLIMBING; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ELECTROPHYSIOLOGY; FORCED SWIMMING TEST; HIPPOCAMPUS; MALE; MUSCLE TONE; NERVE FUNCTION; NEUROTRANSMISSION; NONHUMAN; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SEROTONINERGIC SYSTEM;

EID: 44349148680     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708008547     Document Type: Article

References (45)

1. Aghajanian GK (1978). Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. In : Youdim MBH, Lovenbery W, Sharman DF, Lagnado JR (Eds.), Essays in Neurochemistry and Neuropharmacology (pp. 1-32). New York: Wiley.
2. Artigas F, Nutt DJ, Shelton R (2002). Mechanism of action of antidepressants. Psychopharmacology Bulletin 36 (Suppl. 2), 123-132.
3. Bergeron R, de Montigny C, Debonnel G (1995). Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate. Naunyn-Schmiedebergs Archives of Pharmacology 351, 252-260.
4. Bermack JE, Debonnel G (2001). Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands. British Journal of Pharmacology 134, 691-699.
5. Bermack JE, Debonnel G (2005). The role of sigma receptors in depression. Journal of Pharmacological Sciences 97, 317-336.
6. Besson A, Haddjeri N, Blier P, de Montigny C (2000). Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. European Neuropsychopharmacology 10, 177-188.
7. Blier P, de Montigny C (1994). Current advances and trends in the treatment of depression. Trends in Pharmacological Sciences 15, 220-226.
8. Blier P, de Montigny C (1999). Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21 (Suppl.), 91S-98S.
9. 1A agonists in the treatment of depression? Biological Psychiatry 53, 193-203.
10. Cryan JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23, 238-245.
11. Duman RS, Nakagawa S, Malberg J (2001). Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25, 836-844.
12. El Mansari M, Sanchez C, Chouvet G, Renaud B, Haddjeri N (2005). Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission : an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30, 1269-1277.
13. 3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain. Synapse 20, 54-67.
14. 1A receptors. Journal of Neuroscience 18, 10150-10156.
15. 2+ concentration. Journal of Pharmacology and Experimental Therapeutics 293, 788-798.
16. Kandel ER, Spencer WA (1961). Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. Journal of Neurophysiology 24, 243-259.
17. 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain. Neurochemical Research 22, 1105-1109.
18. 4 agonists. Biological Psychiatry 15, 918-925.
19. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 20, 9104-9110.
20. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976). The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. Journal of Pharmacology and Experimental Therapeutics 197, 517-532.
21. 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. European Journal of Pharmacology 312, 267-271.
22. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T (1994a). Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Research 647, 44-56.
23. 1 receptor agonist. European Journal of Pharmacology 306, 271-279.
24. Maurice T, Hiramatsu M, Kameyama T, Hasegawa T, Nabeshima T (1994b). Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia. Brain Research 647, 57-64.
25. Michelsen KA, Schmitz C, Steinbusch HW (2007). The dorsal raphe nucleus - from silver stainings to a role in depression. Brain Research Reviews. Published online : 17 January 2007. doi:10.1016/j.brainresrev.2007. 01.002.
26. 1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats : an in vivo electrophysiological study. Synapse 33, 129-140.
27. 3H]noradrenaline release in rat hippocampal slices. British Journal of Pharmacology 119, 65-72.
28. Nakagawa S, Kim J-E, Lee R, Malberg JE, Chen J, Steffen C, Zhang Y-J, Nestler EJ, Duman RS (2002). Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. Journal of Neuroscience 22, 3673-3682.
29. Oshiro Y, Sakurai Y, Sato S, Kurahashi N, Tanaka T, Kikuchi T, Tottori K, Uwahodo Y, Miwa T, Nishi T (2000). 3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3- chlorophenyl)-1-piperazinyl]propyl]-3,4-dihydro-5-methoxy-2(1H)-quinolinone and its derivatives. Journal of Medicinal Chemistry 43, 177-189.
30. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates (2nd edn). New York: Academic.
31. Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732.
32. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, Taylor DP (1992). A proposal for the classification of sigma binding sites. Trends in Pharmacological Sciences 13, 85-86.
33. Sadikot AF, Sasseville R (1997). Neurogenesis in the mammalian neostriatum and nucleus accumbens: parvalbumin-immunoreactive GABAergic interneurons. Journal of Comparative Neurology 389, 193-211.
34. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809.
35. Scharfman HE, Hen R (2007). Neuroscience. Is more neurogenesis always better? Science 315, 336-338.
36. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. European Journal of Pharmacology 315, 1-10.
37. 1 receptor agonist. Behavioural Pharmacology 13, 537-543.
38. Soriano E, Del Rio JA (1991). Simultaneous immunocytochemical visualization of bromodeoxyuridine and neural tissue antigens. Journal of Histochemistry and Cytochemistry 39, 255-263.
39. Szabo ST, Blier P (2001). Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. Neuropsychopharmacology 25, 845-857.
40. 1 receptors : implications for antidepressants. Journal of Pharmacology and Experimental Therapeutics 303, 1227-1237.
41. Takebayashi M, Hayashi T, Su TP (2004). A perspective on the new mechanism of antidepressants : neuritogenesis through sigma-1 receptors. Pharmacopsychiatry 37 (Suppl. 3), S208-S213.
42. Ukai M, Maeda H, Nanya Y, Kameyama T, Matsuno K (1998). Beneficial effects of acute and repeated administrations of σ receptor agonists on behavioral despair in mice exposed to tail suspension. Pharmacology, Biochemistry, and Behavior 61, 247-252.
43. 1 receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. Journal of Pharmacology and Experimental Therapeutics 298, 1269-1279.
44. 1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein. European Journal of Pharmacology 486, 151-161.
45. 1 receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats. Neuropharmacology 39, 1617-1627.